Company profile
Unicyte AG company profile
Unicyte AG is a transformative regenerative medicine company advancing stem cell technologies into a novel class of human therapeutics. Unicyte has translated its ground-breaking discoveries into a broad pre-clinical pipeline in key therapeutic areas. The company evolved from a fifteen year research collaboration with Prof Giovanni Camussi, a leading expert on extracellular vesicles and stem cells from the University of Turin and Fresenius Medical Care KGaA, the world’s largest provider of products and services for individuals with renal diseases. Unicyte was founded in 2015 as an independent affiliate of Fresenius Medical Care and is headquartered in Oberdorf NW, Switzerland.
Business identity
- Website
- https://www.unicyte.ch/
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 51-100 employees
- Revenue range
- $1M-$10M
- Founded
- 2015-01-01, Year
Headquarters
- Headquarters
- Oberdorf, Basel-Landschaft, Switzerland
- Country code
- CH
- Continent
- Europe